Scientists tested 39 sweeteners and found unexpected intestinal effects.
Recently, there have been a number of recent developments in the field of international medical health that continue to attract the attention of the industry and the public. According to a study by the University of Cambridge Laboratory, commonly used sweeteners can directly interfere with the growth of bacteria that help support healthy intestines. The strongest effect is seen when researchers combine isotretinoin (a sweetener widely used in the food and beverage industry) with the antidepressant drug Duloxetine.
When the two compounds act separately, it significantly reduces the growth of two important strains of bacteria associated with digestive health. Scientists urge consumers to note that these experiments were conducted in the laboratory and not in the human body. Therefore, further research will be needed in the future to determine whether changes in these two bacterial species have significant health effects in real-world environments.
Sweeteners may not be biologically inactive. Sweeteners are present in countless everyday products, including soft drinks, sweets, desserts, breakfast cereals, snacks, and some medicines. They are often promoted as an alternative to sweeteners to provide sweetness but less sugar or fewer calories.
However, there is increasing evidence that the consumption of sweeteners is linked to a number of diseases, including type 2 diabetes, obesity, and cancer. These associations do not prove that sweeteners directly cause these diseases, and researchers are still struggling to understand the biological processes that may explain these associations. One possible factor is the gut microbiome, large bacteria, and microbiomes that live in the digestive system.
These microbes help digest food, produce useful compounds, train the immune system, and affect metabolism. These changes in the number or balance of these organisms may affect the health of the whole body. Despite the widespread use of sweets, relatively few studies have examined whether sweets directly affect specific gut microbial groups.
Professor Kiran Patil of the Medical Research Council (MRC) Toxicology Unit at the University of Cambridge said: 'Much of what we know about the potential health effects of sweets comes from animal studies or from population studies'. These studies suggest the role of microbiomes in regulating the effects of sweets. However, it is difficult to determine whether sweeteners work in the body by directly interacting with bacteria in our gut, or by disguising bitterness through beverages, snacks or even medications.
These factors further increase the question of how we use sweeteners properly. Sonja Blasche, the lead author of the study and the MRC Toxicology Unit. The 39 sweeteners were tested to assess whether they would cause harm to the human body.
If you have any health questions, please consult a professional medical professional.
